Cellular Phase Chronic Idiopathic Myelofibrosis — Clinical Trials

MONDO:00044632 active·1 recruitingLast updated: Mar 16, 2026, 12:35 AM

Cellular Phase Chronic Idiopathic Myelofibrosis has an emerging clinical trial program, driven by drug treatment.

Recruiting

Active Trials

Drug Treatment2

Phase 1

Phase 2

Phase 3

Academic/Other2

France1 trial

United States1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

2 Trials

Phase 3Recruiting

Sponsor:University Hospital, Brest

FranceStarted: Jul 2022Est. completion: Jul 2027Updated: Feb 2025

Phase 1Active, Not Recruiting

Sponsor:M.D. Anderson Cancer Center

United StatesStarted: Feb 2019Est. completion: Jan 2027Updated: Mar 2026

Stay informed about clinical trials for Cellular Phase Chronic Idiopathic Myelofibrosis.

Follow this disease to get updates when trials open, close, or change status.

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 16, 2026 at 12:35 AM